Weimai

What Weimai does

Weimai (微脉) is a Hangzhou-based digital healthcare company founded in 2015 that operates an integrated online pharmacy, medical device, and teleconsultation platform for Chinese consumers. Its core product is the Weimai Mall (微脉商城) e-commerce marketplace, a third-party platform where verified pharmacies (e.g., Yifeng Pharmacy, Guangzhou Yikangsi Health Pharmacy) and specialty medical device sellers (Sinocare CGMS, fetal heart monitoring, sleep monitoring, BP/ECG monitors) list prescription, OTC, and consumer health products. The Weimai mobile app (微脉APP) connects patients with physicians from Hainan Weimai Internet Hospital for prescriptions and disease management, supporting chronic disease workflows in cardiovascular, diabetes, maternal-fetal, sleep, and pelvic floor care.

Underlying the marketplace is an AI-driven disease management layer that the company positions as supporting managed care models in China, with structured-data processing and predictive analytics over health data. The company has accumulated a full regulatory license stack covering online drug information services, medical device operation, drug network transactions, food sales, and Class II medical device filings, allowing it to operate as a regulated third-party platform rather than a first-party inventory model.

Weimai monetizes through marketplace commissions on third-party transactions and healthcare service fees tied to teleconsultations and prescription fulfillment. Distribution is direct-to-consumer via web and mobile app, with social login via Alipay, WeChat, QQ, and Weibo. The company is privately held, headquartered in Yuhang District, Hangzhou, employs 101–250 people, and has raised approximately USD 257 million across five disclosed funding rounds from 2016 through January 2025, with founders/management retaining control and a roster of Chinese tech and healthcare-focused investors including Baidu Capital, IDG Capital, Matrix Partners China, Source Code Capital, Cenova, CNCB Capital, and government-affiliated investment vehicles.

Name

Weimai

Legal name

微脉技术有限公司

Website

https://myweimai.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

101–250 employees

Short description

Weimai is a Hangzhou-based Chinese digital healthcare company operating a third-party e-commerce marketplace and mobile app (微脉商城/微脉APP) that sells pharmaceuticals, medical devices, and health foods, and connects patients with physicians via Hainan Weimai Internet Hospital for AI-supported disease management and managed care.

Ownership category

akta.pro rank

Product category

Digital Healthcare Marketplace

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)

SIC

Services-Health Services (8000), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Medical Device Connectivity & Interoperability Middleware (MDI, EHR/HL7/FHIR Integration) (HLACAPAJ)

akta.pro secondary industries

Medical, Dental & Lab Supply Marketplaces (CRAFAHAG), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)

Keywords

• Digital healthcare platform
• Online pharmacy marketplace
• Medical device e-commerce
• Disease management solutions
• Internet hospital services

Headquarters

HQ city

Yuhang

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Digital Commerce or Content

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Marketplace Commission: 微脉商城 operates as a third-party marketplace where independent sellers ( pharmacies, medical device companies) sell products. Weimai earns commission from transactions between buyers and sellers.
2. Healthcare Services: Provides digital healthcare services including doctor consultations through the app, connecting patients with doctors from Hainan Weimai Internet Hospital for prescription medications and health management.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels1 record

Core offering

Weimai operates a digital healthcare platform in China combining a third-party e-commerce marketplace (Weimai Mall / 微脉商城) for pharmaceutical products and medical devices with an AI-powered disease management service. The platform connects patients with verified third-party pharmacies and medical device sellers across China, and provides online doctor consultations through the Hainan Weimai Internet Hospital via the Weimai mobile app. Marketplace commissions and healthcare consultation fees form the primary revenue streams.

Product overview

Weimai operates as a digital healthcare solutions provider based in Hangzhou, China, offering a unified platform that combines an AI-powered disease management system with a third-party e-commerce marketplace (微脉商城/Weimai Mall). The core offering includes AI-driven health management solutions for managed care models, while the marketplace connects patients and consumers with verified pharmacies and medical device sellers. Product categories span pharmaceuticals (OTC and prescription Chinese and Western medicines), medical devices (blood pressure monitors, ECG monitors, fetal heart monitors, continuous glucose monitors, sleep monitoring equipment, and rehabilitation devices), and health supplements. The company is Series D funded (USD 27.3 million in early 2025) with focus on expanding AI-powered disease management services throughout China.

Differentiator

Problem solved

Functional benefit

Products and services

• Weimai Mall (微脉商城) Third-party e-commerce marketplace platform operated by Weimai Technology Co., Ltd. (微脉技术有限公司) that connects Chinese consumers with verified third-party pharmacies (such as 益丰大药房 and 广州宜康思健大药房) and medical device sellers (such as 三诺健康管理, 飞思迈科技, 福建恒瑞医疗, 博思凯医疗, 杭州晔龙医疗, 医来说健康). The marketplace lists OTC and prescription medications, medical devices, and health foods across categories including drug information, medical devices, and food information.
• Weimai App (微脉APP) Mobile application serving as the primary customer touchpoint for doctor consultations through Hainan Weimai Internet Hospital, prescription inquiries, and purchasing medications and medical devices. Supports phone number registration and social login via QQ, WeChat, Weibo, and Alipay.
• Hainan Weimai Internet Hospital

Quantifiable outcome

• USD 27.3 million raised in Series D to expand AI-powered health management solutions

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability2 records

Feature1 record

Partnerships

Eight partnerships are on record, tiered core.

• 益丰大药房coreChannel Partner/ Reseller/ DistributorMajor pharmacy chain operating official store on 微脉商城 platform, selling prescription and OTC medications including 金嗓利咽胶囊 and other pharmaceutical products.
• 广州宜康思健康大药房有限公司coreChannel Partner/ Reseller/ DistributorGuangzhou-based pharmacy operating on Weimai Mall platform, selling 999小儿感冒颗粒 and other medications.
• 三诺健康管理有限公司coreChannel Partner/ Reseller/ DistributorHealth management company from Changsha selling medical devices including 动感硅基 (continuous glucose monitoring products) on the platform.
• 飞思迈科科技coreChannel Partner/ Reseller/ DistributorBeijing-based technology company selling medical devices (多导睡眠监测仪 - polysomnography monitoring equipment) on the Weimai Mall platform.
• 福建恒玖医疗投资有限公司coreChannel Partner/ Reseller/ DistributorFujian-based medical investment company selling medical devices including 动感硅基 products on the platform.
• 博思凯（杭州）医疗科技有限公司coreChannel Partner/ Reseller/ DistributorHangzhou-based medical device company selling 远程胎心监护 (remote fetal heart monitoring) products on the platform.
• 杭州昕龙医疗科技有限公司coreChannel Partner/ Reseller/ DistributorHangzhou-based medical device company selling SXL-J1居家盆底康复 (home pelvic floor rehabilitation) products on the platform.
• 医来说（杭州）健康科技有限公司coreChannel Partner/ Reseller/ DistributorHangzhou-based health technology company selling 血压心电监测仪 (blood pressure and ECG monitor) products on the platform.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• JD Health: JD Health (京东健康) is China's largest online healthcare platform combining a pharmaceutical e-commerce marketplace with online consultations and chronic disease management. Most directly comparable to Weimai through its integrated marketplace + telehealth + AI disease management model, though it operates at substantially larger scale under JD.com's ecosystem.
• Alibaba Health: Alibaba Health (阿里健康) is Alibaba Group's healthcare arm combining pharmaceutical e-commerce (via Tmall Medicine) with online consultations, chronic disease management, and AI-driven health insights. Directly comparable to Weimai's marketplace + telehealth model, with significantly greater scale and ecosystem integration via Alibaba's payment and logistics infrastructure.
• Ping An Healthcare and Technology: Ping An Healthcare and Technology (平安健康, formerly Ping An Good Doctor) is one of China's leading telehealth and health management platforms combining online consultations, retail pharmacy, and chronic disease management. Comparable to Weimai through its integrated digital health platform model, with the additional advantage of being backed by Ping An Group's insurance ecosystem.
• WeDoctor: WeDoctor (微医) is a major Chinese digital health platform offering online consultations, hospital appointment booking, and chronic disease management services. Directly comparable to Weimai as a digital health platform serving Chinese consumers with similar AI-enabled care models and online pharmacy services.
• Chunyu Doctor: Chunyu Doctor (春雨医生) is a Chinese digital health platform focused on online doctor consultations, health content, and AI-assisted symptom checking. Comparable to Weimai in digital health consultation services and consumer health engagement, though smaller and more narrowly focused on consultation versus Weimai's broader marketplace model.
• DXY (Dingxiang Yuan): DXY (丁香园) is a Chinese digital health platform combining professional medical content and community with consumer-facing health services, drug information, and disease management tools. Comparable to Weimai in the integrated digital health platform model, with stronger emphasis on health content and professional medical community.
• Medlinker: Medlinker (医联) is a Chinese digital health platform focusing on physician networking, online consultations, and patient management, particularly for chronic diseases. Directly comparable to Weimai in digital health services and chronic disease management focus, with a stronger emphasis on the physician side of the platform.
• Miaoshou Doctor: Miaoshou Doctor (妙手医生) is a Chinese digital health platform providing online consultations, prescription services, and chronic disease management, particularly focused on specialist care. Comparable to Weimai in digital health services and Internet Hospital operations, with similar emphasis on prescription-driven revenue.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds5 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Weimai